Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH

Clinical trial NCT02725372 · TERMINATED

Trial details

NCT number: NCT02725372
Sponsor: Bellerophon Pulse Technologies
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2016-04-01
Primary completion: 2018-08-01
Enrollment: 207

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.